Mind Medicine (MindMed) Inc. (MNMD) Earnings History
Annual and quarterly earnings data from 2015 to 2025
Loading earnings history...
MNMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MNMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export MNMD earnings history in CSV or JSON format
Free sign-in required to download data
Mind Medicine (MindMed) Inc. (MNMD) Earnings Overview
As of May 6, 2026, Mind Medicine (MindMed) Inc. (MNMD) reported trailing twelve-month net income of -$184M, reflecting -1273.3% year-over-year growth. The company earned $-2.06 per diluted share over the past four quarters.
Looking at the long-term picture, MNMD's historical earnings data spans multiple years. The company achieved its highest annual net income of -$92,656 in fiscal 2015.
Mind Medicine (MindMed) Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$288M net income), ATAI (-$154M net income, -48464.0% margin), CYBN (-$123M net income), MNMD has comparable earnings metrics. Compare MNMD vs CMPS →
MNMD Earnings vs Peers
Earnings metrics vs comparable public companies
MNMD Historical Earnings Data (2015–2025)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$184M | -69.1% | -$166M | $-2.06 | - | - |
| 2024 | -$109M | -13.5% | -$104M | $-0.15 | - | - |
| 2023 | -$96M | -68.6% | -$94M | $-2.44 | - | - |
| 2022 | -$57M | +39.0% | -$66M | $-1.84 | - | - |
| 2021 | -$93M | -172.8% | -$94M | $-3.40 | - | - |
| 2020 | -$34M | -2956.2% | -$33M | $-1.92 | - | - |
| 2019 | -$1M | -30.1% | $-468,180 | $-2.94 | - | - |
| 2018 | $-857,944 | +30.1% | $-861,940 | $-2.74 | - | - |
| 2017 | -$1M | -581.9% | -$1M | $-4.85 | - | - |
| 2016 | $-179,900 | -94.2% | $-111,250 | $-2.24 | - | - |
See MNMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MNMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MNMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMNMD — Frequently Asked Questions
Quick answers to the most common questions about buying MNMD stock.
Is MNMD growing earnings?
MNMD EPS fell to $-2.06, with earnings declining -1273.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-184M.
What are MNMD's profit margins?
Mind Medicine (MindMed) Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are MNMD's earnings?
MNMD earnings data spans 2015-2025. The declining earnings trend is -1273.3% YoY. Historical data enables comparison across business cycles.